Evaluation of anti-inflammatory effect of synthetic 1,5-bis(4-acetoxy-3-methoxyphenyl)-1,4-pentadien-3-one, HB2

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 13, 2009, Pages 4290-4295

  Paulino, Niraldo ^a   Rodrigues, Naiara Carvalho ^a   Pardi, Paulo Celso ^a   Suárez, José Agustín Pablo Quincoces ^a   Santos, Reginaldo Pereira dos ^a   Scremin, Amarilis ^b   Vogel, Christian ^c   Feist, Holger ^c   Michalik, Dirk ^d  

^a Universidade Bandeirante de Sao Paulo   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d LEIBNIZ INSTITUT FÜR KATALYSE E V AN DER UNIVERSITÄT ROSTOCK   (Germany)

Author keywords

Anti inflammatory; Nitric oxide; Oedema; Pentadienone; Peritonitis; Prostaglandin E2; RAW 264.7

Indexed keywords

1,5 BIS(4 ACETOXY 3 METHOXYPHENYL) 1,4 PENTADIEN 3 ONE; ANTIINFLAMMATORY AGENT; BENZENE DERIVATIVE; BRADYKININ; DEXAMETHASONE; HB2; INDOMETACIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG SCREENING; DRUG SYNTHESIS; LOCOMOTION; MALE; MOUSE; NONHUMAN; PAW EDEMA; PROSTAGLANDIN SYNTHESIS;

ANALGESICS; ANIMALS; ANISOLES; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; DINOPROSTONE; EDEMA; INFLAMMATION; KETONES; MALE; MICE; NF-KAPPA B; NITRIC OXIDE; PAIN;

MUS;

EID: 66549091731     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.05.034     Document Type: Article

References (35)

1. Glaros T., Larsen M., and Li L. Front Biosci. 14 (2009) 3988
2. Carlsson O., and Rippe B. Am. J. Physiol. 277 (1999) H1107
3. Ohishi S. Yakugaku Zasshi 120 (2000) 455
4. Libby P. Nutr. Rev. 65 (2007) S140
5. Bengmark S. JPEN J. Parenter Enteral Nutr. 30 (2006) 45
6. Paulino N., Teixeira C., Martins R., Scremin A., Dirsch V.M., Vollmar A.M., Abreu S.R., de Castro S.L., and Marcucci M.C. Planta Med. 72 (2006) 899
7. Masuda T., Jitoe A., Isobe J., Nakatani N., and Yonemori S. Phytochemistry 32 (1993) 1557
8. Quincoces, J.; Peseke, K.; Kordian, M.; Carvalho, J.; Brunhari, H.; Kohn, L.; Antônio, M.; Patent PI 0207141-0, 28.11.2002; PCT/BR 2003/000177, 2003; Patent No. US 7,432,401 B2, Oct. 7, 2008.
9. Liang G., Li X., Chen L., Yang S., Wu X., Studer E., Gurley E., Hylemon P.B., Ye F., Li Y., and Zhou H. Bioorg. Med. Chem. Lett. 18 (2008) 1525
10. Liang G., Shao L., Wang Y., Zhao C., Chu Y., Xiao J., Zhao Y., Li X., and Yang S. Bioorg. Med. Chem. 17 (2009) 2623
11. Winter C.A., Risley E.A., and Nuss C.W. Proc. Soc. Exp. Biol. Med. (1962) 544
12. Di Rosa M., and Sorrentino L. Eur. J. Pharmacol. 4 (1968) 340
13. Lima K.V.B. Centro de Ciências da Saúde/LTF, UFPB, João Pessoa 1 (1999) 14
14. Campos M.M., and Calixto J.B. Neuropeptides 34 (2000) 314
15. Sousa P.J.C., Rocha J.C.S., Pessoa A.M., Alves L.A.D., and Carvalho J.C.T. Rev. Bras. Farmaco. 15 (2005) 60
16. Marriot I. Front Biosci. 9 (2004) 2153
17. Calixto J.B., Campos M.M., Otuki M.F., and Santos A.R. Planta Med. 70 (2004) 93
18. Calixto J.B., Cabrini D.A., Ferreira J., and Campos M.M. Pain 87 (2000) 1
19. Strong P., Coleman R.A., and Humphrey P.P. Prostaglandins 43 (1992) 559
20. Coleman R.A., Smith W.L., and Narumiya S. Pharmacol. Rev. 46 (1994) 205
21. Bogdan C. Nat. Immunol. 2 (2001) 907
22. Sharma J.N., Al-Omran A., and Parvathy S.S. Inflammopharmacology 15 (2007) 252
23. Beauparlant P., and Hiscott J. Cytokine Growth Factor Rev. 7 (1996) 175
24. Choi B.H., Kim C.G., Lim Y., Shin S.Y., and Lee Y.H. Cancer Lett. 259 (2008) 111
25. Saja K., Babu M.S., Karunagaran D., and Sudhakaran P.R. Int. Immunopharmacol. 7 (2007) 1659
26. Shirley R.B., Kaddour-Djebbar I., Patel D.M., Lakshmikanthan V., Lewis R.W., and Kumar M.V. Neoplasia 7 (2005) 1104
27. Reyes-Gordillo K., Segovia J., Shibayama M., Vergara P., Moreno M.G., and Muriel P. Biochim. Biophys. Acta 1770 (2007) 989
28. Divya C.S., and Pillai M.R. Mol. Carcinogenesis 45 (2006) 320
29. Meghana K., Sanjeev G., and Ramesh B. Eur. J. Pharmacol. 577 (2007) 183
30. Zimmermann M. Pain 16 (1983) 109
31. Tratsk K.S., Campos M.M., Vaz Z.R., Filho V.C., Schlemper V., Yunes R.A., and Calixto J.B. Inflamm. Res. 46 (1997) 509
32. de Campos R.O., Paulino N., da Silva C.H., Scremin A., and Calixto J.B. J. Pharm. Pharmacol. 50 (1998) 1187
33. Corrêa C.R., and Calixto J.B. Br. J. Pharmacol. 110 (1993) 193
34. Carvalho J.C., Sertié J.A., Barbosa M.V., Patrício K.C., Caputo L.R., Sarti S.J., Ferreira L.P., and Bastos J.K. J. Ethnopharmacol. 64 (1999) 127
35. Kolaczkowska E. Inflamm. Res. 51 (2002) 519